loratadine has been researched along with Liver Diseases in 3 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Eleven treatment-related adverse events, all mild to moderate in severity, were reported." | 2.73 | Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment. ( Gupta, SK; Kantesaria, B; Wang, Z, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, SK | 1 |
| Kantesaria, B | 1 |
| Wang, Z | 1 |
| Najarian, JS | 1 |
| Clark, S | 1 |
1 trial available for loratadine and Liver Diseases
| Article | Year |
|---|---|
Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment.
Topics: Adult; Aged; Analysis of Variance; Area Under Curve; Female; Half-Life; Histamine H1 Antagonists, No | 2007 |
2 other studies available for loratadine and Liver Diseases
| Article | Year |
|---|---|
Hepatic necrosis.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Liver Diseases; Loratadine; Middle Aged; Nec | 1996 |
Dangers of non-sedating antihistamines.
Topics: Arrhythmias, Cardiac; Astemizole; Cetirizine; Heart Diseases; Histamine H1 Antagonists; Humans; Legi | 1997 |